Document Detail


Utilization of wireless pH monitoring technologies: a summary of the proceedings from the Esophageal Diagnostic Working Group.
MedLine Citation:
PMID:  22882487     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Gastroesophageal reflux disease (GERD) can be difficult to diagnose - symptoms alone are often not enough, and thus, objective testing is often required. GERD is a manifestation of pathologic levels of reflux into the esophagus of acidic, nonacidic, and/or bilious gastric content. However, in our current evidence-based knowledge approach, we only have reasonable outcome data in regards to acid reflux, as this particular type of refluxate predictably causes symptoms and mucosal damage, which improves with medical or surgical therapy. While there are data suggesting that nonacid reflux may be responsible for ongoing symptoms despite acid suppression in some patients, outcome data about this issue are limited. Therefore, this working group believes that it is essential to confirm the presence of acid reflux in patients with 'refractory' GERD symptoms or extraesophageal symptoms thought to be caused by gastroesophageal reflux before an escalation of antireflux therapy is considered. If patients do not have pathologic acid reflux off antisecretory therapy, they are unlikely to have clinically significant nonacid or bile reflux. Patients who do not have pathologic acid gastroesophageal reflux parameters on ambulatory pH monitoring then: (i) could attempt to discontinue antisecretory medications like proton pump inhibitors and H2-receptor antagonists (which are expensive and which carry risks - i.e. C. diff, etc.); (ii) may undergo further evaluation for other causes of their esophageal symptoms (e.g. functional heartburn or chest pain, eosinophilic esophagitis, gastroparesis, achalasia, other esophageal motor disorders); and (iii) can be referred to an ear, nose, and throat/pulmonary/allergy physician for assessment of non-GERD causes of their extraesophageal symptoms.
Authors:
J E Richter; J E Pandolfino; M F Vela; P J Kahrilas; B E Lacy; R Ganz; W Dengler; B K Oelschlager; J Peters; K R Devault; R Fass; C P Gyawali; J Conklin; T Demeester
Related Documents :
15993057 - Identification of potent type i metap inhibitors by simple bioisosteric replacement. pa...
10482467 - 2-benzyl-2-methylsuccinic acid as inhibitor for carboxypeptidase a. synthesis and evalu...
18847277 - Practical synthesis of bredemolic acid, a natural inhibitor of glycogen phosphorylase.
12354017 - Concise synthesis of acyl migration-blocked 1,1-difluorinated analogues of lysophosphat...
7598687 - Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates ...
1592227 - A close association between vasoconstrictor-mediated uracil and lactate release by the ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-7
Journal Detail:
Title:  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E     Volume:  -     ISSN:  1442-2050     ISO Abbreviation:  Dis. Esophagus     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8809160     Medline TA:  Dis Esophagus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.
Affiliation:
Esophageal Diagnostic Working Group, Digestive Disease Week 2011, Chicago, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  European consensus document on mast cell tumours in dogs and cats.
Next Document:  Quantifying Acute Changes in Volume and Nutritional Status during Hemodialysis Using Bioimpedance An...